United States Cellular Analyst Ratings
United States Cellular Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/09/2023 | 0.26% | Wells Fargo | $16 → $38 | Upgrades | Underweight → Equal-Weight |
| 08/08/2023 | — | JP Morgan | Upgrades | Neutral → Overweight | |
| 07/26/2023 | -28.76% | Morgan Stanley | $26 → $27 | Maintains | Equal-Weight |
| 07/25/2023 | -28.76% | Morgan Stanley | $26 → $27 | Maintains | Equal-Weight |
| 05/08/2023 | -57.78% | Wells Fargo | $22 → $16 | Maintains | Underweight |
| 02/07/2023 | -36.68% | Morgan Stanley | $37 → $24 | Maintains | Equal-Weight |
| 01/10/2023 | -47.23% | Wells Fargo | $33 → $20 | Downgrades | Overweight → Underweight |
| 11/08/2022 | -36.68% | JP Morgan | $32 → $24 | Upgrades | Underweight → Neutral |
| 11/07/2022 | — | Raymond James | Downgrades | Strong Buy → Market Perform | |
| 08/08/2022 | 2.9% | Raymond James | $41 → $39 | Maintains | Strong Buy |
| 05/09/2022 | 8.18% | Raymond James | $40 → $41 | Maintains | Strong Buy |
| 04/19/2022 | -2.37% | Morgan Stanley | → $37 | Downgrades | Overweight → Equal-Weight |
| 02/22/2022 | -12.93% | Wells Fargo | $36 → $33 | Maintains | Overweight |
| 02/22/2022 | 5.54% | Raymond James | $43 → $40 | Maintains | Strong Buy |
| 08/02/2021 | -5.01% | JP Morgan | $35 → $36 | Downgrades | Neutral → Underweight |
| 07/22/2021 | 31.93% | Morgan Stanley | $50.5 → $50 | Maintains | Overweight |
| 02/22/2021 | -7.65% | JP Morgan | $42 → $35 | Downgrades | Overweight → Neutral |
| 01/14/2021 | 33.25% | Morgan Stanley | $57 → $50.5 | Maintains | Overweight |
| 11/16/2020 | -5.01% | Wells Fargo | → $36 | Reinstates | → Overweight |
| 08/31/2020 | 21.37% | Citigroup | $45 → $46 | Maintains | Buy |
| 08/27/2020 | 50.4% | Morgan Stanley | $56 → $57 | Maintains | Overweight |
| 08/10/2020 | 13.46% | Raymond James | $40 → $43 | Maintains | Strong Buy |
| 07/08/2020 | 47.76% | Morgan Stanley | $57 → $56 | Maintains | Overweight |
| 05/18/2020 | 5.54% | Raymond James | $39 → $40 | Reiterates | → Strong Buy |
| 05/14/2020 | -10.29% | B. Riley Securities | $42 → $34 | Maintains | Neutral |
| 04/22/2020 | 2.9% | Raymond James | $41 → $39 | Maintains | Strong Buy |
| 04/09/2020 | 50.4% | Morgan Stanley | $63 → $57 | Maintains | Overweight |
| 03/27/2020 | 10.82% | JP Morgan | $45 → $42 | Maintains | Overweight |
| 03/02/2020 | 66.23% | Citigroup | $66 → $63 | Maintains | Buy |
| 11/04/2019 | 29.29% | Raymond James | $53 → $49 | Upgrades | Outperform → Strong Buy |
| 11/04/2019 | 18.73% | JP Morgan | → $45 | Upgrades | Neutral → Overweight |
| 08/06/2019 | 5.54% | Wells Fargo | $50 → $40 | Maintains | Market Perform |
| 08/06/2019 | 10.82% | B. Riley Securities | $50 → $42 | Maintains | Neutral |
| 08/05/2019 | 21.37% | JP Morgan | → $46 | Upgrades | Underweight → Neutral |
| 06/18/2019 | 70.18% | Morgan Stanley | $44 → $64.5 | Upgrades | Equal-Weight → Overweight |
| 05/06/2019 | 39.84% | Raymond James | $56 → $53 | Reiterates | → Outperform |
| 11/06/2018 | 47.76% | Raymond James | $43 → $56 | Maintains | Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 08/09/2023 | 0.26% | 富国银行 | $16→$38 | 升级 | 重量不足的→等重 |
| 2023/08/08 | - | 摩根大通 | 升级 | 中性→超重 | |
| 07/26/2023 | -28.76% | 摩根士丹利 | $26→$27 | 维护 | 等重 |
| 07/25/2023 | -28.76% | 摩根士丹利 | $26→$27 | 维护 | 等重 |
| 05/08/2023 | -57.78% | 富国银行 | $22→$16 | 维护 | 体重不足 |
| 02/07/2023 | -36.68% | 摩根士丹利 | $37→$24 | 维护 | 等重 |
| 2023年1月10日 | -47.23% | 富国银行 | $33→$20 | 评级下调 | 增持→减持 |
| 11/08/2022 | -36.68% | 摩根大通 | $32→$24 | 升级 | 减重→中性 |
| 11/07/2022 | - | 雷蒙德·詹姆斯 | 评级下调 | 强劲的购买→市场表现 | |
| 2022/08/08 | 2.9% | 雷蒙德·詹姆斯 | $41→$39 | 维护 | 强势购买 |
| 05/09/2022 | 8.18% | 雷蒙德·詹姆斯 | $40→$41 | 维护 | 强势购买 |
| 04/19/2022 | -2.37% | 摩根士丹利 | →$37 | 评级下调 | 超重→等重 |
| 02/22/2022 | -12.93% | 富国银行 | $36→$33 | 维护 | 超重 |
| 02/22/2022 | 5.54% | 雷蒙德·詹姆斯 | $43→$40 | 维护 | 强势购买 |
| 08/02/2021 | -5.01% | 摩根大通 | $35→$36 | 评级下调 | 中性→减持 |
| 07/22/2021 | 31.93% | 摩根士丹利 | $50.5→$50 | 维护 | 超重 |
| 02/22/2021 | -7.65% | 摩根大通 | $42→$35 | 评级下调 | 超重→中性 |
| 2021/01/14 | 33.25% | 摩根士丹利 | $57→$50.5 | 维护 | 超重 |
| 11/16/2020 | -5.01% | 富国银行 | →$36 | 恢复 | →超重 |
| 08/31/2020 | 21.37% | 花旗集团 | $45→$46 | 维护 | 买 |
| 2020/08/27 | 50.4% | 摩根士丹利 | $56→$57 | 维护 | 超重 |
| 2020/08/10 | 13.46% | 雷蒙德·詹姆斯 | $40→$43 | 维护 | 强势购买 |
| 07/08/2020 | 47.76% | 摩根士丹利 | $57→$56 | 维护 | 超重 |
| 05/18/2020 | 5.54% | 雷蒙德·詹姆斯 | $39→$40 | 重申 | →强势购买 |
| 2020/05/14 | -10.29% | B.莱利证券 | $42→$34 | 维护 | 中性 |
| 04/22/2020 | 2.9% | 雷蒙德·詹姆斯 | $41→$39 | 维护 | 强势购买 |
| 04/09/2020 | 50.4% | 摩根士丹利 | $63→$57 | 维护 | 超重 |
| 03/27/2020 | 10.82% | 摩根大通 | $45→$42 | 维护 | 超重 |
| 03/02/2020 | 66.23% | 花旗集团 | $66→$63 | 维护 | 买 |
| 2019/11/04 | 29.29% | 雷蒙德·詹姆斯 | $53→$49 | 升级 | 跑赢→强势买入 |
| 2019/11/04 | 18.73% | 摩根大通 | →$45 | 升级 | 中性→超重 |
| 2019年08月06日 | 5.54% | 富国银行 | $50→$40 | 维护 | 市场表现 |
| 2019年08月06日 | 10.82% | B.莱利证券 | $50→$42 | 维护 | 中性 |
| 2019年08月05日 | 21.37% | 摩根大通 | →$46 | 升级 | 减重→中性 |
| 2019年06月18日 | 70.18% | 摩根士丹利 | $44→$64.5 | 升级 | 等重→超重 |
| 2019年05月06日 | 39.84% | 雷蒙德·詹姆斯 | $56→$53 | 重申 | →跑赢大盘 |
| 2018/06/11 | 47.76% | 雷蒙德·詹姆斯 | $43→$56 | 维护 | 跑赢大盘 |
What is the target price for United States Cellular (USM)?
美国蜂窝(USM)的目标价是多少？
The latest price target for United States Cellular (NYSE: USM) was reported by Wells Fargo on August 9, 2023. The analyst firm set a price target for $38.00 expecting USM to rise to within 12 months (a possible 0.26% upside). 9 analyst firms have reported ratings in the last year.
富国银行于2023年8月9日报道了美国蜂窝(纽约证券交易所代码：USM)的最新目标价。这家分析公司将目标价定为38.00美元，预计USM将在12个月内上涨至0.26%(可能上涨0.26%)。去年有9家分析公司公布了评级。
What is the most recent analyst rating for United States Cellular (USM)?
美国蜂窝(USM)的最新分析师评级是多少？
The latest analyst rating for United States Cellular (NYSE: USM) was provided by Wells Fargo, and United States Cellular upgraded their equal-weight rating.
美国细胞公司(纽约证券交易所代码：USM)的最新分析师评级由富国银行提供，美国细胞公司上调了其同等权重的评级。
When is the next analyst rating going to be posted or updated for United States Cellular (USM)?
美国蜂窝(USM)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of United States Cellular, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for United States Cellular was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.
分析师在进行了广泛的研究后得出了股票评级，这些研究包括查阅公共财务报表，与United States Ccell的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。美国蜂窝的上一次评级是在2023年8月9日提交的，所以你应该预计下一次评级将在2024年8月9日左右提供。
Is the Analyst Rating United States Cellular (USM) correct?
分析师对美国蜂窝(USM)的评级正确吗？
While ratings are subjective and will change, the latest United States Cellular (USM) rating was a upgraded with a price target of $16.00 to $38.00. The current price United States Cellular (USM) is trading at is $37.90, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的美国蜂窝(USM)评级被上调，目标价为16.00美元至38.00美元。目前美国移动电话(USM)的交易价格为37.90美元，在分析师的预测范围内。